|
|
Other links at Articles > Business of Medicine |
| 1. |
Niacin Plus Laropiprant "Not Approvable" in US
|
|
|
The FDA has issued a "not-approvable" letter to Merck with regard to its new combination, which is being developed as a treatment to raise HDL cholesterol while reducing the flushing associated with niacin alone. However, the product has just received an approval recommendation in Europe. Heartwire
|
| 2. |
Private U.S. Health Plans Targeted in Medicare Bill
|
|
|
U.S. health insurers are targeted for billions in cuts in must-pass legislation that lawmakers will begin debating this week, though other health companies may see benefits. Reuters Health Information
|
| 3. |
World Health Organisation Rejects Taiwan, Again
|
|
|
The World Health Organisation has rejected another bid for membership from Taiwan, an application that was seen as a final jab at China by outgoing President Chen Shui-bian, officials said on Tuesday. Reuters Health Information
|
| 4. |
Drugmakers Urged to Cut Anti-Diarrhoea Vaccine Prices
|
|
|
Health experts at a conference on infectious diseases in the Malaysian capital urged drugmakers on Friday to cut prices of anti-diarrhoea vaccines sold to poorer nations so that more children could benefit from them. Reuters Health Information
|
| 5. |
Diabetes Care -- Insulin Delivery in a Changing World
|
|
|
This review explores how advances in insulin formulations, delivery devices, self-monitoring of blood glucose systems, and disease management tools can improve glycemic control in type 2 diabetes.
The Medscape Journal of Medicine
|
|
|
